10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $492,068 | -98.0% | 8,820 | -97.3% | 0.00% | -96.2% |
| Q1 2022 | $24,994,000 | +109.7% | 328,561 | +310.6% | 0.08% | +166.7% |
| Q4 2021 | $11,920,000 | -47.5% | 80,024 | -48.7% | 0.03% | -44.4% |
| Q3 2021 | $22,717,000 | -16.8% | 156,047 | +11.9% | 0.05% | -15.6% |
| Q2 2021 | $27,305,000 | -9.8% | 139,437 | -16.7% | 0.06% | -19.0% |
| Q1 2021 | $30,283,000 | +253.0% | 167,312 | +176.2% | 0.08% | +259.1% |
| Q4 2020 | $8,579,000 | +105.1% | 60,584 | +80.6% | 0.02% | +83.3% |
| Q3 2020 | $4,182,000 | +91.7% | 33,538 | +37.4% | 0.01% | +71.4% |
| Q2 2020 | $2,181,000 | -52.0% | 24,415 | -66.5% | 0.01% | -30.0% |
| Q1 2020 | $4,540,000 | +71.6% | 72,834 | +109.9% | 0.01% | 0.0% |
| Q4 2019 | $2,646,000 | +776.2% | 34,703 | +478.4% | 0.01% | +900.0% |
| Q3 2019 | $302,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |